Skip Navigation


European Heart Journal Advance Access originally published online on March 8, 2007
European Heart Journal 2007 28(8):918-919; doi:10.1093/eurheartj/ehl554
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/8/918    most recent
ehl554v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Smet, B. J.G.L.
Right arrow Articles by Zijlstra, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Smet, B. J.G.L.
Right arrow Articles by Zijlstra, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

A look at drug eluting stents with optical coherence tomography

Bart J.G.L. de Smet* and Felix Zijlstra

Department of Cardiology, Thorax Centre, University Medical Centre Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands

* Corresponding author. Tel: +31 50 3611347; fax: +31 50 3611347. E-mail address: b.j.g.l.de.smet@thorax.umcg.nl

This editorial refers to ‘Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography’{dagger} by D. Matsumoto et al., on page 961

The first 10% of the full text of this article appears below.

In the last year, following several publications in peer reviewed journals and presentations during the 2006 European Society of Cardiology congress,1 concerns have been raised about a possible increase in the incidence of death and myocardial infarction in patients treated with drug eluting stents (DESs) due to the occurrence of stent thrombosis. The incidence of stent thrombosis in the bare metal stent (BMS) era has become low after the introduction of dual antiplatelet therapy.2 Stent thrombosis in this . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
Daisuke Matsumoto, Junya Shite, Toshiro Shinke, Hiromasa Otake, Yusuke Tanino, Daisuke Ogasawara, Takahiro Sawada, Oscar Luis Paredes, Ken-ichi Hirata, and Mitsuhiro Yokoyama
EHJ 2007 28: 961-967. [Abstract] [Full Text]